Oryx International Builds 8% Holding In Circassia Pharmaceuticals
Oryx International Builds 8% Holding In Circassia Pharmaceuticals
Read moreOryx International Builds 8% Holding In Circassia Pharmaceuticals
Read moreDIRECTOR DEALINGS: Circassia Pharma Chief Operating Officer Buys Stock
Read moreCircassia Pharmaceuticals Loss Widens On Revenue Fall, Costs, Expenses
Read more(Alliance News) - Circassia Pharmaceuticals PLC on Wednesday said Societe Generale SA has built a 14% stake in the company.The French bank initially bought a 9.8% stake in the company on to
Read more(Alliance News) - Circassia Pharmaceuticals PLC said on Tuesday Richard Griffiths and controlled undertakings raised his stake in the company to 28.50%.Prior to this transaction on Friday,
Read more(Alliance News) - Circassia Pharmaceuticals PLC said Monday it has appointed Jonathan Emms to the company's newly created role of chief operating officer.In his new role at the firm, be
Read moreLONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -
Read moreLONDON (Alliance News) - Circassia Pharmaceuticals PLC on Wednesday said its loss narrowed in 2018 as it transitions into a commercial pharmaceutical business, resulting in lower research & is
Read more(Sharecast News) - Circassia narrowed its full-year loss as the company prepares for the launch of Duaklir later in the year, which some analysts believed held the key to putting the company on a firm and sustainable footing going forward, .
Read more(Sharecast News) - Circassia Pharmaceuticals announced on Monday that the US Food and Drug administration had approved its latest treatment for obstructive pulmonary disease called Duaklir.
Read more(Sharecast News) - Specialty pharmaceutical company Circassia Pharmaceuticals has entered into a definitive agreement to acquire exclusive commercialisation rights from AIT Therapeutics to its ventilator compatible nitric oxide product, 'AirNOvent', in the United States and China, it announced on Thursday.
Read more(Sharecast News) - Specialty pharmaceutical company Circassia Pharmaceuticals updated the market on its current trading on Friday, reporting that it ended the year with cash, cash equivalents and short-term deposits of approximately £41m.
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 3.9%, Glencore, up 3.2%,
Read moreLONDON (Alliance News) - Circassia Pharmaceuticals PLC on Friday reiterated its 2019 views and said that it expects strong sales growth following acquisition of full commercial rights to Tudorza a
Read moreLONDON (Alliance News) - Stocks in London were higher early Friday as market sentiment was soothed by positive Chinese economic data and a report of upcoming US-China trade talks.Broker ratings in
Read more